PenderFund Capital Management’s Inozyme Pharma INZY Stock Holding History

PenderFund Capital Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-90,700	Closed	-$363K	–	227
2025 Q2	$363K	Buy	+90,700	New	+$225K	0.09%	68

PenderFund Capital Management's INZY Position: Q3 2025 in Review

PenderFund Capital Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 90,700 shares — an estimated $363K sold.

PenderFund Capital Management first reported a position in INZY in Q2 2025 and held it in 1 quarter. The position peaked at $363K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

PenderFund Capital Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
PenderFund Capital Management sold 90,700 Inozyme Pharma shares in Q3 2025, an estimated $363K.
PenderFund Capital Management first reported a position in Inozyme Pharma in Q2 2025 and held it in 1 quarter.
PenderFund Capital Management's Inozyme Pharma position peaked at $363K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on PenderFund Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.